Rockwell Medical, Inc. (DE) financials
$8.68+0.58%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.8M | $17.3M | $18.3M | $15.9M | $16.1M | $18.9M | $24.7M | $28.3M | $25.8M | $22.7M | $22.1M | $23.8M |
| Gross profit | $3.2M | $2.9M | $3.9M | $2.3M | $2.5M | $3.0M | $3.6M | $6.2M | $4.5M | $3.1M | $2.9M | $2.2M |
| Gross margin | 18.2% | 16.7% | 21.1% | 14.3% | 15.6% | 16.1% | 14.7% | 22.0% | 17.6% | 13.5% | 13.0% | 9.3% |
| Operating income | -$1.1M | -$1.5M | -$398.0K | -$1.6M | -$1.3M | -$1.4M | -$519.0K | $1.9M | $515.0K | -$1.3M | -$547.0K | -$1.7M |
| Net income | -$1.3M | -$1.6M | -$554.0K | -$1.8M | -$1.6M | -$1.5M | -$756.0K | $1.7M | $343.0K | -$1.7M | -$1.5M | -$1.9M |
| Net margin | −7.5% | −9.3% | −3.0% | −11.0% | −10.2% | −8.0% | −3.1% | 5.9% | 1.3% | −7.6% | −6.8% | −7.9% |
| Diluted EPS | $-0.34 | $-0.40 | $-0.08 | $-0.50 | $-0.48 | $-0.40 | $-0.25 | $0.40 | $0.10 | $-0.60 | $-0.52 | $-0.70 |
| EBITDA | -$569.0K | -$969.0K | $148.0K | -$1.0M | -$786.0K | -$821.0K | $24.0K | $2.5M | $1.1M | -$779.0K | $3.0K | -$1.2M |
| Operating cash flow | $2.1M | -$167.0K | $2.3M | -$1.3M | $1.8M | -$3.5M | $865.0K | $4.3M | $1.4M | -$2.4M | -$43.0K | -$3.8M |
| Free cash flow | $1.5M | -$592.0K | $2.2M | -$1.5M | $1.7M | -$3.5M | $470.0K | $4.1M | $1.2M | -$2.5M | -$86.0K | -$3.8M |
| Diluted shares | 4.0M | 3.9M | 7.0M | 3.6M | 3.4M | 3.4M | 3.0M | 3.2M | 3.2M | 2.9M | 2.9M | 2.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.5M | $9.6M | $10.7M | $13.6M | $12.5M | $11.4M |
| Short-term investments | $14.3M | $14.3M | $14.3M | $10.1M | $5.9M | $5.9M |
| Total debt | $9.5M | $9.6M | $9.9M | $10.1M | $10.5M | $10.0M |
| Total assets | $56.5M | $57.4M | $57.1M | $57.5M | $52.6M | $54.0M |
| Total liabilities | $21.4M | $21.6M | $20.2M | $20.5M | $22.2M | $22.4M |
| Shareholders' equity | $35.1M | $35.9M | $37.0M | $37.0M | $30.4M | $31.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology